Inhibitory potency of 2-aryl-2,3-dihydrobenzo[h]quinolin-4(1H)-ones 1a–d and their 3-hydroxy derivatives 2a,b against CYP1B1, 1A1, and 1A2.
| |||||||
|---|---|---|---|---|---|---|---|
| Compound | R1 | R | IC50 values (nM) | IC50 ratio | |||
| 1B1 | 1A1 | 1A2 | 1A1/1B1 | 1A2/1B1 | |||
| 1a | H | H | 131.4 | 404.6 | 952.8 | 3.1 | 7.3 |
| 1b | H | 3,4,5-TriOCH3 | 20.2 | 44.6 | >5000 | 2.2 | >247.5 |
| 1c | H | o-F | 139.3 | 577.5 | 1097 | 4.1 | 7.9 |
| 1d | H | m-F | 98.6 | 493.2 | 1045 | 5.0 | 10.6 |
| 2a | OH | H | 259.6 | 587.9 | 1411 | 2.3 | 5.4 |
| 2b | OH | 3,4,5-TriOCH3 | 302.5 | 1161 | >5000 | 3.8 | >16.5 |
| ANF | — | — | 5.6 | 62.8 | 14.1 | 11.2 | 2.5 |